Karen Lewis - 23 Feb 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief People Officer
Signature
/s/ David Watson, attorney-in-fact for Karen Lewis
Issuer symbol
APLS
Transactions as of
23 Feb 2023
Net transactions value
-$75,911
Form type
4
Filing time
27 Feb 2023, 15:32:17 UTC
Previous filing
22 Feb 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $75,911 -1,104 -2.6% $68.76 41,430 23 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale originated from established 10b5-1 trading plan.